您的购物车当前为空
Nrf2 activator-4 是一种具有口服活性的 Nrf2 激活剂(EC50: 0.63 μM),对小神经胶质细胞中活性氧的产生有抑制作用,用于治疗人类代谢功能障碍相关的脂肪肝病。

Nrf2 activator-4 是一种具有口服活性的 Nrf2 激活剂(EC50: 0.63 μM),对小神经胶质细胞中活性氧的产生有抑制作用,用于治疗人类代谢功能障碍相关的脂肪肝病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 497 | In Stock |
Nrf2 activator-4 相关产品
| 产品描述 | Nrf2 activator-4 is an Nrf2 activator that inhibits the production of reactive oxygen species in microglia for the treatment of fatty liver disease associated with metabolic dysfunction in humans. |
| 分子量 | 468.9 |
| 分子式 | C23H24ClF3N2O3 |
| CAS No. | 2383016-68-8 |
| Smiles | Cl.CN1CCN(CC1)C(=O)COc1ccc(cc1)C(=O)\C=C\c1ccccc1C(F)(F)F |
| 存储 | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (170.61 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.04 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容